BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11675645)

  • 1. Coronary magnetic resonance angiography: experimental evaluation of the new rapid clearance blood pool contrast medium P792.
    Taupitz M; Schnorr J; Wagner S; Kivelitz D; Rogalla P; Claassen G; Dewey M; Robert P; Corot C; Hamm B
    Magn Reson Med; 2001 Nov; 46(5):932-8. PubMed ID: 11675645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved MR coronary angiography with use of a new rapid clearance blood pool contrast agent in pigs.
    Dirksen MS; Lamb HJ; Kunz P; Robert P; Corot C; de Roos A
    Radiology; 2003 Jun; 227(3):802-8. PubMed ID: 12676975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MR angiography of the coronary arteries: comparison of the blood pool contrast medium Gadomer and Gd-DTPA in pigs].
    Schnorr J; Wagner S; Ebert W; Heyer C; Laub G; Kivelitz D; Abramjuk C; Hamm B; Taupitz M
    Rofo; 2003 Jun; 175(6):822-9. PubMed ID: 12811696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced magnetic resonance angiography: P792 blood pool agent versus Gd-DOTA in rabbits at 3.0 T versus 1.5 T.
    Herborn CU; Watkins DM; Baumann S; Robert P; Corot C; Runge VM
    Invest Radiol; 2007 Sep; 42(9):622-8. PubMed ID: 17700277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity.
    Port M; Corot C; Violas X; Robert P; Raynal I; Gagneur G
    Invest Radiol; 2005 Sep; 40(9):565-73. PubMed ID: 16118549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits.
    Ruehm SG; Christina H; Violas X; Corot C; Debatin JF
    Magn Reson Med; 2002 Nov; 48(5):844-51. PubMed ID: 12417999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of myocardial infarction in pigs using a rapid clearance blood pool contrast medium.
    Dewey M; Kaufels N; Laule M; Schnorr J; Wagner S; Kivelitz D; Raynaud JS; Robert P; Hamm B; Taupitz M
    Magn Reson Med; 2004 Apr; 51(4):703-9. PubMed ID: 15065242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadobenate dimeglumine (Gd-DTPA) vs gadopentetate dimeglumine (Gd-BOPTA) for contrast-enhanced magnetic resonance angiography (MRA): improvement in intravascular signal intensity and contrast to noise ratio.
    Pediconi F; Fraioli F; Catalano C; Napoli A; Danti M; Francone M; Venditti F; Nardis P; Passariello R
    Radiol Med; 2003; 106(1-2):87-93. PubMed ID: 12951555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extremely Small Pseudoparamagnetic Iron Oxide Nanoparticle as a Novel Blood Pool T1 Magnetic Resonance Contrast Agent for 3 T Whole-Heart Coronary Angiography in Canines: Comparison With Gadoterate Meglumine.
    Park EA; Lee W; So YH; Lee YS; Jeon BS; Choi KS; Kim EG; Myeong WJ
    Invest Radiol; 2017 Feb; 52(2):128-133. PubMed ID: 27977466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR diagnosis of a pulmonary embolism: comparison of P792 and Gd-DOTA for first-pass perfusion MRI and contrast-enhanced 3D MRA in a rabbit model.
    Keilholz SD; Bozlar U; Fujiwara N; Mata JF; Berr SS; Corot C; Hagspiel KD
    Korean J Radiol; 2009; 10(5):447-54. PubMed ID: 19721829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium.
    Taupitz M; Schnorr J; Wagner S; Abramjuk C; Pilgrimm H; Kivelitz D; Schink T; Hansel J; Laub G; Hünigen H; Hamm B
    Radiology; 2002 Jan; 222(1):120-6. PubMed ID: 11756715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced magnetic resonance angiography of the supraaortic vessels at 3 Tesla.
    Bueltmann E; Erb G; Kirchin MA; Klose U; Naegele T
    Invest Radiol; 2008 Oct; 43(10):695-702. PubMed ID: 18791411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3.0-T whole-heart coronary magnetic resonance angiography: comparison of gadobenate dimeglumine and gadofosveset trisodium.
    Raman FS; Nacif MS; Cater G; Gai N; Jones J; Li D; Sibley CT; Liu S; Bluemke DA
    Int J Cardiovasc Imaging; 2013 Jun; 29(5):1085-94. PubMed ID: 23515949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the iron oxide-based blood-pool contrast medium VSOP-C184 with gadopentetate dimeglumine for first-pass magnetic resonance angiography of the aorta and renal arteries in pigs.
    Schnorr J; Wagner S; Abramjuk C; Wojner I; Schink T; Kroencke TJ; Schellenberger E; Hamm B; Pilgrimm H; Taupitz M
    Invest Radiol; 2004 Sep; 39(9):546-53. PubMed ID: 15308937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced magnetic resonance angiography with biodegradable (Gd-DTPA)-cystamine copolymers: comparison with MS-325 in a swine model.
    Nguyen TD; Spincemaille P; Vaidya A; Prince MR; Lu ZR; Wang Y
    Mol Pharm; 2006; 3(5):558-65. PubMed ID: 17009855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal functional contrast-enhanced magnetic resonance imaging: evaluation of a new rapid-clearance blood pool agent (p792) in sprague-dawley rats.
    Mandry D; Pedersen M; Odille F; Robert P; Corot C; Felblinger J; Grenier N; Claudon M
    Invest Radiol; 2005 May; 40(5):295-305. PubMed ID: 15829826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gd-BOPTA: "the MRA contrast agent of choice"?
    Fellner F; Janka R; Fellner C; Dobritz M; Lenz M; Lang W; Bautz W
    Rontgenpraxis; 1999; 52(2):51-8. PubMed ID: 10431568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.